Centrillion Technology, Inc.

Centrillion Technology, Inc. is a biotechnology company with a mission to provide DNA chips that can map biological molecules at a sub-cellular level in biological tissues. Founded in 2009, the company's research and product development operations are focused on bridging technologies for large-scale genomic analyses and informatics. Operating in the United States, Centrillion aims to empower researchers, physicians, and consumers with responsible and cost-effective access to genomic information to advance personalized health care, molecular diagnostics, and individualized wellness management. With a focus on Biotechnology, Life Sciences, and Clean Energy, Centrillion has positioned itself at the forefront of innovation in the healthcare and biotech industry. The company received a corporate round investment on 01 August 2018 and has garnered positive reception from academic and industrial customers for its high-quality genomic services. The absence of specific investors for the last round of investment indicates the company's potential for attracting diverse sources of funding and interest within the industry.